PDL BioPharma (PDLI) Reports In-Line Q3 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. TFII
10. ORCL

Go back to PDL BioPharma (PDLI) Reports In-Line Q3 EPS

PDL BioPharma Announces Third Quarter 2016 Financial Results

November 3, 2016 4:02 PM EDT

INCLINE VILLAGE, Nev., Nov. 3, 2016 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today reported financial results for the third quarter ended September 30, 2016 including:

Total revenues of $53.6 million and $177.8 million for the three and nine months ended September 30, 2016, respectively. GAAP diluted EPS of $0.08 and $0.45 for the three and nine months ended September 30, 2016, respectively. GAAP net income attributable to PDL's shareholders of $13.9 million and $73.9 million for the three and nine months ended September 30, 2016, respectively. Non-GAAP net income of $18.9 million and $118.2 million for the... More